nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0124	0.332	CbGbCtD
Alfuzosin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0115	0.308	CbGbCtD
Alfuzosin—Terazosin—ABCB1—peripheral nervous system neoplasm	0.00747	0.412	CrCbGaD
Alfuzosin—Doxazosin—ABCB1—peripheral nervous system neoplasm	0.00555	0.306	CrCbGaD
Alfuzosin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00527	0.142	CbGbCtD
Alfuzosin—Prazosin—ABCB1—peripheral nervous system neoplasm	0.00512	0.282	CrCbGaD
Alfuzosin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00483	0.13	CbGbCtD
Alfuzosin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0033	0.0885	CbGbCtD
Alfuzosin—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.0014	0.00149	CcSEcCtD
Alfuzosin—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.0014	0.00149	CcSEcCtD
Alfuzosin—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.0014	0.00148	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00139	0.00148	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00139	0.00147	CcSEcCtD
Alfuzosin—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00139	0.00147	CcSEcCtD
Alfuzosin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00139	0.00147	CcSEcCtD
Alfuzosin—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00139	0.00147	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00139	0.00147	CcSEcCtD
Alfuzosin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00138	0.00146	CcSEcCtD
Alfuzosin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00138	0.00146	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00144	CcSEcCtD
Alfuzosin—Malaise—Etoposide—peripheral nervous system neoplasm	0.00136	0.00144	CcSEcCtD
Alfuzosin—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00144	CcSEcCtD
Alfuzosin—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00136	0.00144	CcSEcCtD
Alfuzosin—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00135	0.00143	CcSEcCtD
Alfuzosin—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00135	0.00143	CcSEcCtD
Alfuzosin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00135	0.00143	CcSEcCtD
Alfuzosin—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00135	0.00142	CcSEcCtD
Alfuzosin—Infection—Cisplatin—peripheral nervous system neoplasm	0.00134	0.00141	CcSEcCtD
Alfuzosin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00134	0.00141	CcSEcCtD
Alfuzosin—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00133	0.00141	CcSEcCtD
Alfuzosin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00132	0.0014	CcSEcCtD
Alfuzosin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00132	0.0014	CcSEcCtD
Alfuzosin—Rash—Topotecan—peripheral nervous system neoplasm	0.00132	0.0014	CcSEcCtD
Alfuzosin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00132	0.0014	CcSEcCtD
Alfuzosin—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00132	0.0014	CcSEcCtD
Alfuzosin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00132	0.00139	CcSEcCtD
Alfuzosin—Headache—Topotecan—peripheral nervous system neoplasm	0.00132	0.00139	CcSEcCtD
Alfuzosin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00131	0.00139	CcSEcCtD
Alfuzosin—Rash—Tretinoin—peripheral nervous system neoplasm	0.00131	0.00139	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00131	0.00139	CcSEcCtD
Alfuzosin—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00131	0.00139	CcSEcCtD
Alfuzosin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00131	0.00139	CcSEcCtD
Alfuzosin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00131	0.00139	CcSEcCtD
Alfuzosin—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00131	0.00139	CcSEcCtD
Alfuzosin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00131	0.00138	CcSEcCtD
Alfuzosin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00131	0.00138	CcSEcCtD
Alfuzosin—Headache—Tretinoin—peripheral nervous system neoplasm	0.00131	0.00138	CcSEcCtD
Alfuzosin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00131	0.00138	CcSEcCtD
Alfuzosin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.0013	0.00138	CcSEcCtD
Alfuzosin—Constipation—Vincristine—peripheral nervous system neoplasm	0.0013	0.00138	CcSEcCtD
Alfuzosin—Pain—Vincristine—peripheral nervous system neoplasm	0.0013	0.00138	CcSEcCtD
Alfuzosin—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.0013	0.00138	CcSEcCtD
Alfuzosin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.0013	0.00138	CcSEcCtD
Alfuzosin—Rash—Melphalan—peripheral nervous system neoplasm	0.0013	0.00137	CcSEcCtD
Alfuzosin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.0013	0.00137	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00129	0.00137	CcSEcCtD
Alfuzosin—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00129	0.00136	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.00128	0.00136	CcSEcCtD
Alfuzosin—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.00128	0.00136	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00128	0.00135	CcSEcCtD
Alfuzosin—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00127	0.00134	CcSEcCtD
Alfuzosin—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.00127	0.00134	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.00127	0.00134	CcSEcCtD
Alfuzosin—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00126	0.00133	CcSEcCtD
Alfuzosin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00125	0.00133	CcSEcCtD
Alfuzosin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00125	0.00132	CcSEcCtD
Alfuzosin—Nausea—Topotecan—peripheral nervous system neoplasm	0.00125	0.00132	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00124	0.00132	CcSEcCtD
Alfuzosin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00124	0.00131	CcSEcCtD
Alfuzosin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00124	0.00131	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00123	0.0013	CcSEcCtD
Alfuzosin—Infection—Etoposide—peripheral nervous system neoplasm	0.00122	0.0013	CcSEcCtD
Alfuzosin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00122	0.00129	CcSEcCtD
Alfuzosin—Nausea—Melphalan—peripheral nervous system neoplasm	0.00122	0.00129	CcSEcCtD
Alfuzosin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00121	0.00128	CcSEcCtD
Alfuzosin—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.0012	0.00127	CcSEcCtD
Alfuzosin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.0012	0.00127	CcSEcCtD
Alfuzosin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.0012	0.00127	CcSEcCtD
Alfuzosin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00119	0.00126	CcSEcCtD
Alfuzosin—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00126	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00126	CcSEcCtD
Alfuzosin—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.00118	0.00125	CcSEcCtD
Alfuzosin—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.00118	0.00124	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00124	CcSEcCtD
Alfuzosin—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.00117	0.00124	CcSEcCtD
Alfuzosin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00117	0.00123	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00116	0.00123	CcSEcCtD
Alfuzosin—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00115	0.00122	CcSEcCtD
Alfuzosin—Pain—Cisplatin—peripheral nervous system neoplasm	0.00115	0.00122	CcSEcCtD
Alfuzosin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00113	0.0012	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.00113	0.0012	CcSEcCtD
Alfuzosin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00112	0.00118	CcSEcCtD
Alfuzosin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00111	0.00117	CcSEcCtD
Alfuzosin—Somnolence—Etoposide—peripheral nervous system neoplasm	0.0011	0.00116	CcSEcCtD
Alfuzosin—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.00109	0.00116	CcSEcCtD
Alfuzosin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00109	0.00116	CcSEcCtD
Alfuzosin—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00115	CcSEcCtD
Alfuzosin—Infestation—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00115	CcSEcCtD
Alfuzosin—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00115	CcSEcCtD
Alfuzosin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00108	0.00115	CcSEcCtD
Alfuzosin—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.00108	0.00114	CcSEcCtD
Alfuzosin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.00114	CcSEcCtD
Alfuzosin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00107	0.00114	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00106	0.00113	CcSEcCtD
Alfuzosin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00106	0.00112	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00112	CcSEcCtD
Alfuzosin—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00112	CcSEcCtD
Alfuzosin—Constipation—Etoposide—peripheral nervous system neoplasm	0.00105	0.00112	CcSEcCtD
Alfuzosin—Pain—Etoposide—peripheral nervous system neoplasm	0.00105	0.00112	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00111	CcSEcCtD
Alfuzosin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00104	0.00111	CcSEcCtD
Alfuzosin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00104	0.0011	CcSEcCtD
Alfuzosin—Sweating—Epirubicin—peripheral nervous system neoplasm	0.00104	0.0011	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00108	CcSEcCtD
Alfuzosin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00108	CcSEcCtD
Alfuzosin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00102	0.00108	CcSEcCtD
Alfuzosin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00101	0.00107	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00101	0.00107	CcSEcCtD
Alfuzosin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00101	0.00107	CcSEcCtD
Alfuzosin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.001	0.00106	CcSEcCtD
Alfuzosin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.001	0.00106	CcSEcCtD
Alfuzosin—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.001	0.00106	CcSEcCtD
Alfuzosin—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.001	0.00106	CcSEcCtD
Alfuzosin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000996	0.00105	CcSEcCtD
Alfuzosin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000995	0.00105	CcSEcCtD
Alfuzosin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000989	0.00105	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000982	0.00104	CcSEcCtD
Alfuzosin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000979	0.00104	CcSEcCtD
Alfuzosin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000977	0.00103	CcSEcCtD
Alfuzosin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000975	0.00103	CcSEcCtD
Alfuzosin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000974	0.00103	CcSEcCtD
Alfuzosin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000967	0.00102	CcSEcCtD
Alfuzosin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000965	0.00102	CcSEcCtD
Alfuzosin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000965	0.00102	CcSEcCtD
Alfuzosin—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000961	0.00102	CcSEcCtD
Alfuzosin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.00096	0.00102	CcSEcCtD
Alfuzosin—Rash—Vincristine—peripheral nervous system neoplasm	0.000959	0.00102	CcSEcCtD
Alfuzosin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000958	0.00101	CcSEcCtD
Alfuzosin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000956	0.00101	CcSEcCtD
Alfuzosin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000953	0.00101	CcSEcCtD
Alfuzosin—Headache—Vincristine—peripheral nervous system neoplasm	0.000953	0.00101	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000948	0.001	CcSEcCtD
Alfuzosin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.00094	0.000995	CcSEcCtD
Alfuzosin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000938	0.000993	CcSEcCtD
Alfuzosin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00092	0.000974	CcSEcCtD
Alfuzosin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000909	0.000962	CcSEcCtD
Alfuzosin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000904	0.000957	CcSEcCtD
Alfuzosin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000902	0.000955	CcSEcCtD
Alfuzosin—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000902	0.000955	CcSEcCtD
Alfuzosin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000902	0.000955	CcSEcCtD
Alfuzosin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000893	0.000945	CcSEcCtD
Alfuzosin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000889	0.000941	CcSEcCtD
Alfuzosin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000884	0.000936	CcSEcCtD
Alfuzosin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000884	0.000936	CcSEcCtD
Alfuzosin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000882	0.000934	CcSEcCtD
Alfuzosin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000882	0.000934	CcSEcCtD
Alfuzosin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000876	0.000928	CcSEcCtD
Alfuzosin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000872	0.000923	CcSEcCtD
Alfuzosin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000855	0.000905	CcSEcCtD
Alfuzosin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000852	0.000902	CcSEcCtD
Alfuzosin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000848	0.000898	CcSEcCtD
Alfuzosin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000847	0.000897	CcSEcCtD
Alfuzosin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000843	0.000893	CcSEcCtD
Alfuzosin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000841	0.00089	CcSEcCtD
Alfuzosin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000835	0.000884	CcSEcCtD
Alfuzosin—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000835	0.000884	CcSEcCtD
Alfuzosin—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000819	0.000867	CcSEcCtD
Alfuzosin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000816	0.000864	CcSEcCtD
Alfuzosin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000815	0.000863	CcSEcCtD
Alfuzosin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000811	0.000858	CcSEcCtD
Alfuzosin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000799	0.000846	CcSEcCtD
Alfuzosin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000788	0.000834	CcSEcCtD
Alfuzosin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000785	0.000831	CcSEcCtD
Alfuzosin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000784	0.00083	CcSEcCtD
Alfuzosin—Rash—Etoposide—peripheral nervous system neoplasm	0.000777	0.000823	CcSEcCtD
Alfuzosin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000776	0.000822	CcSEcCtD
Alfuzosin—Headache—Etoposide—peripheral nervous system neoplasm	0.000772	0.000817	CcSEcCtD
Alfuzosin—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000763	0.000808	CcSEcCtD
Alfuzosin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000761	0.000805	CcSEcCtD
Alfuzosin—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000759	0.000804	CcSEcCtD
Alfuzosin—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000758	0.000802	CcSEcCtD
Alfuzosin—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000748	0.000792	CcSEcCtD
Alfuzosin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000744	0.000788	CcSEcCtD
Alfuzosin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000732	0.000775	CcSEcCtD
Alfuzosin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000727	0.000769	CcSEcCtD
Alfuzosin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000721	0.000763	CcSEcCtD
Alfuzosin—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000721	0.000763	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000716	0.000758	CcSEcCtD
Alfuzosin—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000712	0.000754	CcSEcCtD
Alfuzosin—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000706	0.000748	CcSEcCtD
Alfuzosin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000705	0.000746	CcSEcCtD
Alfuzosin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000704	0.000745	CcSEcCtD
Alfuzosin—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000702	0.000744	CcSEcCtD
Alfuzosin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000692	0.000733	CcSEcCtD
Alfuzosin—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000691	0.000731	CcSEcCtD
Alfuzosin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000688	0.000729	CcSEcCtD
Alfuzosin—Infection—Epirubicin—peripheral nervous system neoplasm	0.000686	0.000727	CcSEcCtD
Alfuzosin—Shock—Epirubicin—peripheral nervous system neoplasm	0.00068	0.00072	CcSEcCtD
Alfuzosin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000677	0.000717	CcSEcCtD
Alfuzosin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000676	0.000716	CcSEcCtD
Alfuzosin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000674	0.000714	CcSEcCtD
Alfuzosin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000671	0.00071	CcSEcCtD
Alfuzosin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000668	0.000707	CcSEcCtD
Alfuzosin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000667	0.000706	CcSEcCtD
Alfuzosin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000667	0.000706	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000662	0.000701	CcSEcCtD
Alfuzosin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000659	0.000697	CcSEcCtD
Alfuzosin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000652	0.00069	CcSEcCtD
Alfuzosin—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000646	0.000683	CcSEcCtD
Alfuzosin—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000639	0.000677	CcSEcCtD
Alfuzosin—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000635	0.000672	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000629	0.000666	CcSEcCtD
Alfuzosin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000629	0.000666	CcSEcCtD
Alfuzosin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000627	0.000664	CcSEcCtD
Alfuzosin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000626	0.000663	CcSEcCtD
Alfuzosin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000624	0.00066	CcSEcCtD
Alfuzosin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000621	0.000657	CcSEcCtD
Alfuzosin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000618	0.000654	CcSEcCtD
Alfuzosin—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000614	0.00065	CcSEcCtD
Alfuzosin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000608	0.000644	CcSEcCtD
Alfuzosin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000597	0.000632	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000596	0.000631	CcSEcCtD
Alfuzosin—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000596	0.000631	CcSEcCtD
Alfuzosin—Pain—Epirubicin—peripheral nervous system neoplasm	0.000591	0.000625	CcSEcCtD
Alfuzosin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000591	0.000625	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000582	0.000617	CcSEcCtD
Alfuzosin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000569	0.000603	CcSEcCtD
Alfuzosin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000568	0.000602	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000565	0.000598	CcSEcCtD
Alfuzosin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000563	0.000596	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000552	0.000584	CcSEcCtD
Alfuzosin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000551	0.000583	CcSEcCtD
Alfuzosin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000549	0.000581	CcSEcCtD
Alfuzosin—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000547	0.000579	CcSEcCtD
Alfuzosin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000547	0.000579	CcSEcCtD
Alfuzosin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000546	0.000578	CcSEcCtD
Alfuzosin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000527	0.000558	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000523	0.000553	CcSEcCtD
Alfuzosin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000508	0.000538	CcSEcCtD
Alfuzosin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000505	0.000535	CcSEcCtD
Alfuzosin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000496	0.000525	CcSEcCtD
Alfuzosin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000489	0.000517	CcSEcCtD
Alfuzosin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000473	0.0005	CcSEcCtD
Alfuzosin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000459	0.000486	CcSEcCtD
Alfuzosin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000457	0.000484	CcSEcCtD
Alfuzosin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000452	0.000479	CcSEcCtD
Alfuzosin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000439	0.000465	CcSEcCtD
Alfuzosin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000437	0.000463	CcSEcCtD
Alfuzosin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000436	0.000461	CcSEcCtD
Alfuzosin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000435	0.000461	CcSEcCtD
Alfuzosin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000433	0.000458	CcSEcCtD
Alfuzosin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000423	0.000447	CcSEcCtD
Alfuzosin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00041	0.000434	CcSEcCtD
Alfuzosin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000406	0.00043	CcSEcCtD
Alfuzosin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.000427	CcSEcCtD
Alfuzosin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.000426	CcSEcCtD
Alfuzosin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.000424	CcSEcCtD
Alfuzosin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.000402	CcSEcCtD
